NAMPT and cancer: Increases in cellular NAD levels, produced by overexpression of NAMPT or exogenous application of NAD metabolites, have been associated with enhanced cancer growth and greater resistance to anticancer agents (Cairns et al., 2011; Chiarugi et al., 2012) and inhibition of NAMPT is currently under evaluation as an adjuvant in chemotherapy regimens.